Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Samrat Pharmachem Ltd Stock Analysis

Small Cap
Evaluated by 144 users | BSE: 530125 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 15.89%32.06%6.44%4.59%4.47%3.61%10.53%15.23%8.35%16.35%17.29%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 44.47172.166.248.563.272.892.9111137179209
Y-o-Y Gr. Rt.-59.9%1.6%-8.1%-26.8%30.4%15.1%27.8%19.6%23.7%30.2%-
Adjusted EPS (Rs.) 4.3412.231.30.781.060.955.6510.414.9713.7417.322.14
Y-o-Y Gr. Rt.-181.8%-89.4%-40%35.9%-10.4%494.7%84.3%-52.3%176.5%25.9%-
Book Value per Share (Rs.) 28.2240.4541.7442.5243.5544.5249.5759.9864.9578.6695.92108.04
Adjusted Net Profit 1.33.80.40.20.30.31.73.21.54.35.37
Net Op. Cash Flow (Rs. Cr.) -0.84-23.9-0.6-0.4-3.20.12.4-1.34.8-
Debt to Cash Flow from Ops -2.130.86-2.130.82-5.85-15.41-2.1571.882.75-7.11.82-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Samrat Pharmachem Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 10.8%23.2%24.4%30.2%
Adjusted EPS 3.9%78.7%18.5%25.9%
Book Value per Share 10.116.616.921.9
Share Price 20.4% 40.6% 58% 65.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 16.6835.633.151.862.462.161219.017.9619.1419.8221.71
Operating Profit Margin (%) 5.428.961.711.052.381.895.076.42.864.824.844.83
Net Profit Margin (%) 3.035.330.560.370.670.462.43.461.383.092.993.28
Debt to Equity 0.190.270.330.240.240.40.450.510.330.390.30
Working Capital Days 92851041111201031169889938498
Cash Conversion Cycle 231614152023334645403736
Loading price chart...
Entity Percentage Holding
Promoters 49.30%
Institutions 3.24%
Non-Institutions 47.46%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Samrat Pharmachem Ltd's earnings have grown by 78.7%, whereas share price has appreciated 40.6% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Samrat Pharmachem Ltd share price has appreciated 20.4% annually (CAGR) over the past ten years.

Data is not available for this company.

Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed &

Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed & traded on the Bombay Stock Exchange & other bourses of India. The company is presently employing 30 people for its operations at Ankleshwar & Mumbai.

The company’s manufacturing unit & test laboratory is situated in Ankleshwar. The factory is spread in an area of 3645 sq. mtrs. & has a constructed area of 20000 sq. ft. Technical innovation is their core strength. If anything is possible chemically, they strain their nerves to make it a reality. Research & Development is multi faceted focusing both on product & process development. Their commitment to keep the atmosphere beautiful & pure inspires them for further improvement in the process techniques.

The company is having a modern & well equipped quality control laboratory manned by experienced professionals who have set high standards for testing & approval. Starting with the raw materials, the intermediate stages & right upto the final stage, the products are continuously monitored for quality. The company's products & laboratory is approved by the Food & Drug Administration, Gandhinagar, Gujarat.

Samrat is well equipped to discharge its function round the year without any breakdown under adverse conditions. The company has fully computerized, centrally located office in the heart of Mumbai. Excellent documentation & personal attention to all national & international order ensures smooth & flawless logistical services. The company has well trained staff to meet any contingencies. Safe, convenient & tamper proof packaging ensures easy handling & reliability.The company is heading towards being accredited ISO 9000 & ISO 14000 Certification shortly.

The company is heading towards ERP implementation, which will integrate all the activities of the company on the internet thereby giving speedy information & reports.

Product range of the company includes:

Samrat has a major chunk of the business in Iodine & Bromine Salts. The company's customers include several multinational companies in India & Abroad. The company is exporting a part of its products to USA, Europe, Japan etc.

  • Calcium Iodate Monohydrate
  • Copper Iodide
  • Hydriodic Acid 47% 
  • Hydriodic Acid 57%
  • Iodine 
  • Iodine Monochloride
  • Iodoethane (Ethyl iodide)
  • Iodomethane (Methyl iodide)
  • Potassium Bromide
  • Potassium Iodate
  • Potassium Iodide
  • Potassium Metaperiodate
  • Sodium Iodate
  • Sodium Iodide
  • Sodium Metaperiodate
  • Trimethyl Sulfoxoniumiodide

Achievements/ recognition :

  • The company's products & laboratory is approved by the Food & Drug Administration, Gandhinagar, Gujarat.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback